Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-02-09 @ 1:29 PM
Study NCT ID:
NCT03518060
Status:
COMPLETED
Last Update Posted:
2024-10-16
First Post:
2018-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1
Sponsor:
ViiV Healthcare
Organization: